T1	Disorder 979 990	sarcoidosis
T3	Disorder 809 812	IPF
T4	GGPs 411 415	TSLP
T5	GGPs 1815 1820	IL-33
T10	Disorder 1327 1330	IPF
T11	GGPs 1433 1437	TSLP
T22	Disorder 874 878	NSIP
T23	GGPs 1185 1189	TSLP
T25	GGPs 1825 1829	TSLP
T28	Subject 549 557	patients
T29	GGPs 16 30	interleukin-33
T34	Disorder 87 116	idiopathic pulmonary fibrosis
T38	Anatomical_entity 78 83	lungs
T41	Disorder 1666 1669	IPF
T43	Disorder 1793 1796	IPF
T47	Disorder 1345 1357	lung disease
T48	Subject 324 337	animal models
T50	GGPs 210 238	thymic stromal lymphopoietin
T51	Disorder 647 651	NSIP
T54	Disorder 595 598	IPF
T57	Subject 795 803	patients
T60	GGPs 1596 1601	IL-33
T64	Disorder 1499 1502	IPF
T67	Disorder 1114 1117	IPF
T68	GGPs 35 63	thymic stromal lymphopoietin
T69	Disorder 709 720	sarcoidosis
T70	GGPs 1576 1580	TSLP
T71	GGPs 744 748	TSLP
T72	Disorder 302 320	pulmonary fibrosis
T74	Disorder 564 593	idiopathic pulmonary fibrosis
T76	Disorder 1246 1249	IPF
T78	Disorder 1885 1888	IPF
T81	GGPs 753 758	IL-33
T85	Disorder 662 690	hypersensitivity pneumonitis
T86	Disorder 1680 1705	interstitial lung disease
T90	GGPs 240 244	TSLP
T92	GGPs 1453 1458	IL-33
T93	GGPs 428 433	IL-33
T94	GGPs 1194 1199	IL-33
N3	Reference T1 UMLS:C0036202	Sarcoidosis
N12	Reference T3 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N45	Reference T10 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N94	Reference T22 UMLS:C1290344	Nonspecific interstitial pneumonia
N118	Reference T28 UMLS:C0030705	Patients
N123	Reference T29 UMLS:C3540587	Interleukin-33
N132	Reference T34 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N147	Reference T38 UMLS:C0024109	Lung
N152	Reference T41 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N160	Reference T43 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N170	Reference T47 UMLS:C0024115	Lung diseases
N172	Reference T48 UMLS:C0599779	Animal Model
N179	Reference T50 UMLS:C0762640	thymic stromal lymphopoietin
N182	Reference T51 UMLS:C1290344	Nonspecific interstitial pneumonia
N193	Reference T54 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N202	Reference T57 UMLS:C0030705	Patients
N213	Reference T60 UMLS:C3540587	Interleukin-33
N225	Reference T64 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N235	Reference T67 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N241	Reference T68 UMLS:C0762640	thymic stromal lymphopoietin
N245	Reference T69 UMLS:C0036202	Sarcoidosis
N258	Reference T72 UMLS:C0034069	Pulmonary Fibrosis
N262	Reference T74 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N268	Reference T76 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N273	Reference T78 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N287	Reference T81 UMLS:C3540587	Interleukin-33
N294	Reference T85 UMLS:C0002390	Extrinsic allergic alveolitis
N296	Reference T86 UMLS:C0206062	Lung Diseases, Interstitial
N320	Reference T92 UMLS:C3540587	Interleukin-33
N326	Reference T93 UMLS:C3540587	Interleukin-33
N332	Reference T94 UMLS:C3540587	Interleukin-33
T96	Disorder 692 694	HP
N1	Reference T96 UMLS:C0002390	Extrinsic allergic alveolitis
T97	Disorder 926 928	HP
N2	Reference T97 UMLS:C0002390	Extrinsic allergic alveolitis
T98	Disorder 1900 1934	chronic interstitial lung diseases
N4	Reference T98 UMLS:C0746105	Chronic interstitial lung disease
T30	Disorder 610 645	non-specific interstitial pneumonia
N7	Reference T30 UMLS:C1290344	Nonspecific interstitial pneumonia
T55	Anatomical_entity 466 495	bronchoalveolar lavage fluids
N9	Reference T55 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T40	Anatomical_entity 1840 1850	BAL fluids
N10	Reference T40 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T44	Cell 138 153	T helper type 2
N11	Reference T44 UMLS:C0242633	T-helper cell type 2
T79	Cell 155 158	Th2
N13	Reference T79 UMLS:C0242633	T-helper cell type 2
N14	Reference T90 UMLS:C0762640	thymic stromal lymphopoietin
N15	Reference T4 UMLS:C0762640	thymic stromal lymphopoietin
N16	Reference T71 UMLS:C0762640	thymic stromal lymphopoietin
N17	Reference T23 UMLS:C0762640	thymic stromal lymphopoietin
N18	Reference T11 UMLS:C0762640	thymic stromal lymphopoietin
N19	Reference T70 UMLS:C0762640	thymic stromal lymphopoietin
N20	Reference T25 UMLS:C0762640	thymic stromal lymphopoietin
T80	GGPs 189 208	interleukin (IL)-33
N23	Reference T80 UMLS:C3540587	Interleukin-33
N21	Reference T5 UMLS:C3540587	Interleukin-33
T15	GGPs 251 256	IL-25
N22	Reference T15 UMLS:C1450336	IL25 protein, human
T53	GGPs 417 422	IL-25
N26	Reference T53 UMLS:C1450336	IL25 protein, human
T65	GGPs 1053 1058	IL-25
N28	Reference T65 UMLS:C1450336	IL25 protein, human
T12	Subject 991 997	groups
N29	Reference T12 UMLS:C1257890	Population Group
T37	Subject 1358 1364	groups
N34	Reference T37 UMLS:C1257890	Population Group
T62	Subject 1706 1712	groups
N40	Reference T62 UMLS:C1257890	Population Group
T2	Subject 510 525	normal controls
N5	Reference T2 UMLS:C0009932	Control Groups
T8	Subject 527 530	NCs
N6	Reference T8 UMLS:C0009932	Control Groups
T14	Subject 829 832	NCs
N8	Reference T14 UMLS:C0009932	Control Groups
T21	Subject 1107 1109	NC
N35	Reference T21 UMLS:C0009932	Control Groups
T27	Subject 1254 1263	NC groups
N36	Reference T27 UMLS:C0009932	Control Groups
T63	Subject 1507 1516	NC groups
N37	Reference T63 UMLS:C0009932	Control Groups
T24	Subject 1118 1123	group
N38	Reference T24 UMLS:C1257890	Population Group
T89	Subject 1358 1364	groups
N43	Reference T89 UMLS:C1257890	Population Group
T91	Subject 1706 1712	groups
N44	Reference T91 UMLS:C1257890	Population Group
T99	Subject 600 607	n = 100
N46	Reference T99 UMLS:C0030705	Patients
T100	Subject 653 659	n = 22
N47	Reference T100 UMLS:C0030705	Patients
T101	Subject 696 702	n = 20
N48	Reference T101 UMLS:C0030705	Patients
T102	Subject 722 728	n = 19
N49	Reference T102 UMLS:C0030705	Patients
R1	member_of Arg1:T99 Arg2:T28	
R2	member_of Arg1:T100 Arg2:T28	
R3	member_of Arg1:T101 Arg2:T28	
R4	member_of Arg1:T102 Arg2:T28	
R5	Subject_Disorder Arg1:T48 Arg2:T72	
R10	Subject_Disorder Arg1:T57 Arg2:T3	
R11	Subject_Disorder Arg1:T89 Arg2:T10	
R12	Subject_Disorder Arg1:T37 Arg2:T47	
R14	Subject_Disorder Arg1:T91 Arg2:T41	
R15	Subject_Disorder Arg1:T62 Arg2:T86	
R6	Subject_Disorder Arg1:T28 Arg2:T74	
T13	Subject 549 557	patients
N30	Reference T13 UMLS:C0030705	Patients
T83	Subject 549 557	patients
N41	Reference T83 UMLS:C0030705	Patients
T103	Subject 549 557	patients
N50	Reference T103 UMLS:C0030705	Patients
R7	Subject_Disorder Arg1:T103 Arg2:T30	
R8	Subject_Disorder Arg1:T83 Arg2:T85	
R9	Subject_Disorder Arg1:T13 Arg2:T69	
T105	Positive_regulation 0 12	Upregulation
E3	Positive_regulation:T105 Theme:T68 atLoc:T38 disorder:T34
N52	Reference E3 UMLS:C1879547	Activation action
T106	Positive_regulation 177 185	mediated
E4	Positive_regulation:T106 Cause:T50 Theme:E8
N53	Reference E4 UMLS:C1879547	Activation action
T107	Subject 532 538	n = 40
N54	Reference T107 UMLS:C0009932	Control Groups
A1	Count_sbjct T107
R16	member_of Arg1:T107 Arg2:T2	
A2	Count_sbjct T99
A3	Count_sbjct T100
A4	Count_sbjct T101
A5	Count_sbjct T102
E5	Positive_regulation:T105 Theme:T29 atLoc:T38 disorder:T34
N55	Reference E5 UMLS:C1879547	Activation action
T18	Biological_process 131 137;160 176	Innate immune responses
E8	Biological_process:T18 
N57	Reference E8 UMLS:C0020969	Immunity, Innate
E7	Positive_regulation:T106 Cause:T15 Theme:E8
N56	Reference E7 UMLS:C1879547	Activation action
E9	Positive_regulation:T106 Cause:T80 Theme:E8
N58	Reference E9 UMLS:C1879547	Activation action
T9	Biological_process 1727 1750	Innate immune responses
E1	Biological_process:T9 
N42	Reference E1 UMLS:C0020969	Immunity, Innate
T73	Correlation 1758 1768	associated
E2	Correlation:T73 Theme:E1 Theme2:E6 Cue:T61
T84	Correlation 276 298	play an important role
E10	Correlation:T84 Theme:T72 Theme2:E8 Cue:T58
N24	Reference E2 UMLS:C0332281	Associated with
N25	Reference E10 UMLS:C0332281	Associated with
T7	Biological_process 1778 1789	development
E6	Biological_process:T7 Theme:T43
N31	Reference E6 UMLS:C0699748	Pathogenesis
T6	Subject 1257 1263	groups
N27	Reference T6 UMLS:C1257890	Population Group
T19	Subject 1510 1516	groups
N33	Reference T19 UMLS:C1257890	Population Group
R13	Subject_Disorder Arg1:T6 Arg2:T76	
R23	Subject_Disorder Arg1:T19 Arg2:T64	
R24	Subject_Disorder Arg1:T24 Arg2:T67	
T42	Subject 991 997	groups
N39	Reference T42 UMLS:C1257890	Population Group
T52	Subject 991 997	groups
N51	Reference T52 UMLS:C1257890	Population Group
R25	Subject_Disorder Arg1:T12 Arg2:T22	
R26	Subject_Disorder Arg1:T42 Arg2:T97	
R27	Subject_Disorder Arg1:T52 Arg2:T1	
T58	Speculation_cue 267 272	shown
A6	Speculated E10
R28	part_of Arg1:T55 Arg2:T2	
R29	part_of Arg1:T55 Arg2:T13	
R30	part_of Arg1:T55 Arg2:T83	
R31	part_of Arg1:T55 Arg2:T28	
R32	part_of Arg1:T55 Arg2:T103	
T61	Speculation_cue 1751 1754	may
A7	Speculated E2
